PODD INSULET CORP
Debt Financing ·
Morgan Stanley Senior Funding, Inc. is administrative agent. The margin on the refinanced term loans falls 0.25%, and cash and cash equivalents were $534.9 million at June 30, 2026, down from $716.1 million at the end of 2025.
We have not published a story on INSULET CORP yet. When there is news, it will appear here.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $2.71 billion | $2.07 billion |
| Research and development | $301.1 million | $219.6 million |
| Net income (loss) | $247.1 million | $418.3 million |
| Cash from operations | $569.3 million | $430.2 million |
| Cash and equivalents | $716.1 million | $953.4 million |
INSULET CORP trades under the ticker PODD on NASDAQ.
INSULET CORP is listed on NASDAQ.
Our directory records INSULET CORP under United States.
aibio.space lists INSULET CORP among 2,820 public biotech companies and publishes its news here as stories appear.
$2.71 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.
INSULET CORP reported net income of $247.1 million for the fiscal year ended Dec 31, 2025, and generated $569.3 million of cash from operations, per its annual report to the SEC.
$301.1 million in the fiscal year ended Dec 31, 2025, per its annual report.
$534.9 million in cash at Jun 30, 2026, per its 10-Q.
Our latest story on INSULET CORP, dated Sep 21, 2026: "Insulet amends credit agreement, refinancing $475 million in term loans". Morgan Stanley Senior Funding, Inc. is administrative agent. The margin on the refinanced term loans falls 0.25%, and cash and cash equivalents were $534.9 million at June 30, 2026, down from $716.1 million at the end of 2025. Source.
Our latest debt story, dated Sep 21, 2026: "Insulet amends credit agreement, refinancing $475 million in term loans". Morgan Stanley Senior Funding, Inc. is administrative agent. The margin on the refinanced term loans falls 0.25%, and cash and cash equivalents were $534.9 million at June 30, 2026, down from $716.1 million at the end of 2025. Source.
Press Follow on this page to add INSULET CORP to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming INSULET CORP so far, in Debt Financing.
Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-Q. Source
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio